Satellite Technology News

powered by google

Satellite Spotlight:  

Satellite Technology RSS Feed
Share

TMCNet:  DARA, OPTR, SATS, SLTM, SUSS, CIU Are Seasonally Ripe To Go Down In the Next Five Weeks

[March 25, 2013]

DARA, OPTR, SATS, SLTM, SUSS, CIU Are Seasonally Ripe To Go Down In the Next Five Weeks

Mar 25, 2013 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of DARA Biosciences Inc (NASDAQ:DARA), Optimer Pharmaceuticals Inc (NASDAQ:OPTR), EchoStar Corp (NASDAQ:SATS), Solta Medical Inc (NASDAQ:SLTM), Susser Holdings Corp (NASDAQ:SUSS), Ishares Barclays Intermediate Credit Bond Fund (NYSE:CIU) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php The following stocks are expected to go Down: Symbol Company Expected Return Odds By The Following Date DARA DARA Biosciences Inc -8.01% 84.62% (11 of 13) Wednesday, March 27th 2013 OPTR Optimer Pharmaceuticals Inc -0.90% 100.00% (6 of 6) Tuesday, March 26th 2013 SATS EchoStar Corp -3.01% 100.00% (5 of 5) Tuesday, April 16th 2013 SLTM Solta Medical Inc -3.93% 66.67% (4 of 6) Wednesday, March 27th 2013 SUSS Susser Holdings Corp -1.36% 100.00% (6 of 6) Thursday, March 28th 2013 CIU Ishares Barclays Intermediate Credit Bond Fund -0.41% 66.67% (4 of 6) Tuesday, April 2nd 2013 DARA Biosciences Inc (NASDAQ:DARA) - DARA BioSciences, Inc., a development stage biopharmaceutical company, engages in the development and commercialization of oncology treatment and supportive care pharmaceutical products in the United Sates. Its products include Soltamox for the treatment of breast cancer; Gemcitabine for first-line therapy for ovarian, breast, lung and pancreatic cancers; and other cancer support therapeutics, as well as generic sterile injectable cytotoxic products. Its drug development programs include KRN5500, a non-narcotic/non-opioid that has completed Phase IIa clinical trial for the treatment of neuropathic pain in cancer patients; and DB959, which has completed a Phase I study for the treatment of metabolic diseases, including type 2 diabetes and dyslipidemia. The company s pre-clinical drug candidate includes DB900 PPAR gamma/alpha/delta agonists for development in metabolic and inflammatory diseases; DB160, DPPIV enzyme inhibitors with applications in diabetes, stem cell transplantation, and cancer therapy; and DB200, Carnitine palmitoyltransferase-1 for skin diseases, including psoriasis. DARA BioSciences, Inc. was incorporated in 2002 and is headquartered in Raleigh, North Carolina..

Optimer Pharmaceuticals Inc (NASDAQ:OPTR) - Optimer Pharmaceuticals, Inc., a biopharmaceutical company, focuses on development and commercialization of pharmaceutical products. It offers fidaxomicin tablets, an antibacterial drug for the treatment of adult patients with Clostridium difficile-associated diarrhea (CDAD). The company sells its fidaxomicin products through wholesalers to hospitals, retail, and specialty pharmacies in the United States. It also has fidaxomicin under Phase IIIB clinical trials for the treatment of CDAD prophylaxis and CDAD in oncology patients; and under Phase II clinical trials for the treatment of pediatric CDAD treatment. In addition, the company has Solithromycin product under Phase II clinical trials for the treatment of respiratory tract infections; and OPT-822/821 product under Phase II/III clinical trials for the treatment of breast cancer. It has collaborative agreements with Cubist Pharmaceuticals, Inc.; Astellas Pharma Europe Ltd.; Par Pharmaceuticals, Inc.; Biocon Limited; Patheon Inc.; Cempra Pharmaceuticals, Inc.; Optimer Biotechnology, Inc.; Memorial Sloan-Kettering Cancer Center; and Scripps Research Institute. The company was founded in 1998 and is based in San Diego, California..

EchoStar Corp (NASDAQ:SATS) - EchoStar Corporation, together with its subsidiaries, engages in the design, development, and distribution of digital set-top boxes and related products. The company s EchoStar Technologies segment designs, develops, and distributes digital set-top boxes and related products and technology, including Slingbox placeshifting technology primarily for satellite television (TV) service providers, and telecommunication and cable companies that allow consumers to watch and control their home digital video and audio content through a broadband Internet connection; and Slingboxes for consumers through retail outlets. This segment also provides digital broadcast operations comprising satellite uplinking/downlinking, transmission services, signal processing, conditional access management, and other services primarily to DISH Network. Its EchoStar Satellite Services segment offers capacity leasing on a full-time and occasional-use basis primarily to DISH Network, as well as to Dish Mexico, the U.S. government service providers, state agencies, Internet service providers, broadcast news organizations, programmers, and private enterprise customers through its 10 owned and leased in-orbit satellites and related Federal Communications Commission licenses. The company s Hughes segment provides satellite broadband Internet access to consumers in North America; broadband network services and systems to the domestic and international enterprise markets; managed services and equipment to enterprises; turnkey satellite ground segment systems to mobile system operators; and microwave radio network systems for cellular backhaul and broadband wireless access. It has operations in North America, Asia, Africa, Australia, Europe, South America, and the Middle East. EchoStar Corporation was founded in 2007 and is headquartered in Englewood, Colorado..

Solta Medical Inc (NASDAQ:SLTM) - Solta Medical, Inc., together with its subsidiaries, engages in the design, development, manufacture, and marketing of energy-based medical device systems for aesthetic applications primarily in North America, the Asia Pacific, Europe, and the Middle East. It offers Fraxel re:pair system for use in dermatological procedures requiring ablation, coagulation, and resurfacing of soft tissue, as well as for rhytides, pigmentation, dyschromia, fine lines, acne, surgical scars, deeper lines, wrinkles, and actinic keratoses; and Clear + Brilliant system for patients who want to take control of their aging process. The company also provides Thermage CPT system that provides non-invasive treatment options for skin tightening; Liposonix system to destroy unwanted fat cells resulting in waist circumference reduction; Isolaz system for the treatment of inflammatory acne, comedonal acne, and mild to moderate inflammatory acne; and the CLARO device, a consumer handheld device for the treatment of mild-to-moderate inflammatory acne, including pustular acne. Its customers principally include dermatologists, plastic surgeons, general and family practitioners, gynecologists, and ophthalmologists. The company sells its products primarily through a direct sales force, as well as through independent distributors; and CLARO device through retail and associated retailer s Websites, and television retail networks, as well as through its own website in the United States. The company was formerly known as Thermage, Inc. and changed its name to Solta Medical, Inc. in January 2009. Solta Medical, Inc. was incorporated in 1996 and is headquartered in Hayward, California..

Susser Holdings Corp (NASDAQ:SUSS) - Susser Holdings Corporation, together with its subsidiaries, operates convenience stores in Texas, New Mexico, and Oklahoma. The company operates in two segments, Retail and Wholesale. The Retail segment operates convenience stores that offer merchandise, food service, and motor fuel, as well as provides other services, including car washes, lottery, ATM, money orders, prepaid phone cards and wireless services, and movie rentals. As of February 27, 2013, it operated approximately 560 convenience stores under the Stripes banner. The Wholesale segment distributes motor fuel to its retail convenience stores, contracted independent operators of convenience stores, unbranded convenience stores, unattended fueling facilities, and other end users in Texas, New Mexico, Oklahoma, and Louisiana. The company also offers environmental, maintenance, and construction management services to the petroleum industry; and sells and installs motor fuel dispensers and tanks, as well as provides a range of environmental consulting services, such as hydrocarbon remediation, and Phase I and II site assessments for its stores and outside customers. Susser Holdings Corporation is based in Corpus Christi, Texas..

Ishares Barclays Intermediate Credit Bond Fund (NYSE:CIU) - iShares Trust iShares Lehman Intermediate Credit Bond Fund.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com SqueezeTrigger is a registered trademark, Reg. No. 3,120,641 CONTACT: Buyins.net Thomas Ronk tom@buyins.net www.buyins.net ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to info@m2.com.

[ Satellite Spotlight's Homepage ]


blog comments powered by Disqus

FREE Satellite eNewsletter

Subscribe to our free weekly Satellite Spotlight eNewsletter!

Get the latest expert news, reviews & resources. Tailored specifically for Satellite Technology and Communications.

Satellite Technology White Papers

Innovative Features Mean Major Savings for Cellular Operators Using Satellite Backhaul
With the rising cost of satellite bandwidth and the need for more of it to support an ever increasing number of voice, data and now video services, operators must seek ways to reduce both their hardware investment costs and operating expenses, especially when fierce competition forces them to provide these new services without raising their rates.

Satellite Technology Features